Death rates due to acute myocardial infarction in cancer patients with and without the use of SNP “patch” and in the normal counterparts.

aData cited in Harrison's Principles of Internal Medicine, 16th Edition, Volume 2, Chapter 208, Approach to the Patient with Cardiovascular Disease by Eugene Braunwald pp 1301, McGraw-Hill Medical Publishing Division.bData cited in Sinha AK, et al. Neutralization by “antineoplastin” of insulin-activated nitric oxide synthase antibody and its effects in cancers. J Cancer Res Clin Oncol. 2002 Dec;128(12):659–68.cData cited in Harrison's Principles of Internal Medicine, 16th Edition, Volume 1, Chapter 66, Approach to the Patient with Cancer by Dan L. Longo pp-435. McGraw-Hill Medical Publishing Division and other journal articles reporting the statistical significance of the occurrence of AMI in cancer patients.Sodium Nitroprusside “pad” was prepared and used dermally in patients with different kinds of cancers (n = 8,283) as described in the Materials and Methods in details.Death rates due to AMI in the cancer patients who received SNP “pad” for 3 years was compared to the rate of death due to AMI in the normal population as reported in the literature.The death rates between the groups were compared by using Z-test, a special case of null hypothesis.